Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 706
Selected: 0
NCT IDTitle
NCT00362271Aripiprazole and Effexor XR Drug Interaction Study
NCT00002130A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons
NCT01925521OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects.
NCT07848334First-in-Human Safety and Tolerability Study of OPF-110 in Healthy Adults
NCT01423916Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
NCT02282085Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia
NCT01122927Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
NCT02088697A Bioequivalence Study of ASC-01 Placebo (Aripiprazole 0 mg/Sertraline 100 mg) and Sertraline Tablet in Healthy Male Subjects
NCT01895322Open-label Dose-finding Trial of OPC-41061 in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis
NCT01702831Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance
NCT04907279Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE)
NCT01940159A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia
NCT01723059Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
NCT04100096A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder
NCT03254108Clinical Pharmacology Trial to Investigate the Dose of OPC-61815 Injection Equivalent to Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure
NCT00361790Aripiprazole and Lexapro Drug Interaction Study
NCT01013532PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
NCT02336347A Phase 1 Study Comparing AVP-786 With AVP-923
NCT02722863Samsca Post Marketing Surveillance Study
NCT05615363A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])
NCT04182958A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects
NCT06937593A Study to Evaluate Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Multiple Doses of VIS954
NCT02105285Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
NCT02534038Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition
NCT01432444Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
NCT01145313Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Disorder
NCT03406286Samsca PMS in ADPKD Patients
NCT05463770A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia
NCT03585127Avatar Therapy in Comparison to Cognitive Behavioral Therapy for Treatment-resistant Schizophrenia
NCT03303079Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine
NCT06637514A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria
NCT03719443First in Human Study to Assess Safety of VIS649 in Healthy Subjects
NCT00479336A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema
NCT00234078Dose-response Study of OPC-12759 Ophthalmic Suspension
NCT03470233Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB
NCT00095745A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder
NCT03620981Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
NCT00462670A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)
NCT06926829A Long-term Trial of EB-1020 in Adult Patients With ADHD
NCT02545101An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH
NCT00545675Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness
NCT02442674A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia
NCT00237913Schizophrenia Trial of Aripiprazole
NCT00706589Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder
NCT05439148OPC-61815 in Healthy Chinese Male Subjects
NCT01862640A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation
NCT01727700Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT01981811Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
NCT06036108Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
NCT03259555A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder